Literature DB >> 2976092

A new criterion for selection of pharmacokinetic multiexponential equations.

B P Imbimbo1, E Imbimbo, S Daniotti, D Verotta, G Bassotti.   

Abstract

In linear pharmacokinetics, the time course of the plasma concentration of a drug, Ct, is expressed by the sum of exponential terms, (formula; see text) This article proposes a new statistical criterion for discriminating between alternate polyexponential models. According to this new criterion, the model that best interprets a set of experimental data points is that which minimizes the area between the approximate confidence limits of Ct.

Mesh:

Substances:

Year:  1988        PMID: 2976092     DOI: 10.1002/jps.2600770914

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.

Authors:  M A Arangoa; M A Campanero; M J Renedo; G Ponchel; J M Irache
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Pharmacokinetic study of orally administered zinc in humans: evidence for an enteral recirculation.

Authors:  J Nève; M Hanocq; A Peretz; F Abi Khalil; F Pelen; J P Famaey; J Fontaine
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

5.  Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.

Authors:  W Weber; M Nitz; M Looby
Journal:  J Pharmacokinet Biopharm       Date:  1990-12

6.  Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

Authors:  T M Ludden; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1994-10

7.  The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure.

Authors:  F Gianese; M T Nurmohamed; B P Imbimbo; H R Büller; R J Berckmans; J W Ten Cate
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

8.  A new method to estimate parameters of pharmacokinetics with enterohepatic circulation.

Authors:  F Abi Khalil; M Hanocq; J Dubois
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

9.  Statistics or pharmacokinetics?

Authors:  V K Piotrovskij
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

10.  Pharmacokinetics of daunorubicin and daunorubicinol in plasma, P388 and B16 tumours. Comparison with in vitro cytotoxicity data.

Authors:  J Dubois; M Hanocq; G Atassi; R Arnould; F Abikhalil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.